GENE THERAPY RESOURCE PROGRAM (GTRP) Header
GENE THERAPY RESOURCE PROGRAM (GTRP) Header
NHLBI GENE THERAPY GROUP
HIGHLIGHTS
» Instructions for Submitting
   an RSA

» RSA Review Process
INFORMATION CENTER
»NHLBI Home
»FAQ's
»Regulatory Resources

  » Regulatory Guidelines

  » Fundamental Elements in
    Gene Vector Development

»National Gene Vector
  Biorepository
  » Article - April 2009
»Publications and Presentations
  by GTRP Investigators
The membership of the NHLBI Gene Therapy Group is comprised of the Group Leader (Dr. Sonia Skarlatos), Project Officers from each division of the NHLBI, and members of the Grants Management Office and Office of Acquisitions.  Ancillary members may be appointed by the group leader. 

The Gene Therapy Group is charged with oversight and overall management of all components of the GTRP including development and maintenance of program infrastructure.  This includes:

  • Developing and implementing Bylaws and Policies of the GTRP
  • Creating committees, review boards, and working groups as deemed appropriate including delegation of responsibility and authority
  • Determining (as the sole review group) disposition of Request for Service Applications for Preclinical Vector Production and Regulatory Support Services
  • Determining final disposition of Request for Service Applications for GMP-grade Vector Production, Pharmacology/Toxicology Testing, and Clinical Trial Funding Assistance

Business of the Gene Therapy Group is conducted primarily through face-to-face meetings and teleconferences.

» Gene Therapy Group Roster

Login for the Gene Therapy Group Members to access RSA and FA forms, RSA Status Reports, the Manual of Operations, and the GTRP directory.

 
Investigator Registration | Request for Service Application | Core Laboratories | Scientific Review Board | Steering Committee | NHLBI Gene Therapy Group